La transplantation d'intestin grêle

Pierre Charbonnet, Leo Bühler, Zakiyah Kadry, Pietro Majno, Philippe Morel

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Since the development of new immunosuppressive agents, as FK506, the results of small bowel transplantation have greatly improved. The patient survival at one year has increased from 25% during the ciclosporine aera to 65% in 1995 and the graft survival from 19% to 57% respectively. Clearly, the postoperative complications are still frequent and severe and do not allow a wide generalisation of this method. However, total parental nutrition is not an appropriate solution for the long term management of patients with terminal intestinal insufficiency. In Switzerland, these patients survive for several years and finally die of problems that small bowel transplantation could already successfully overpass.

Original languageFrench
Pages (from-to)337-341
Number of pages5
JournalRevue Medicale de la Suisse Romande
Volume117
Issue number4
StatePublished - Apr 1 1997

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Charbonnet, P., Bühler, L., Kadry, Z., Majno, P., & Morel, P. (1997). La transplantation d'intestin grêle. Revue Medicale de la Suisse Romande, 117(4), 337-341.